Skip navigation
Please use this identifier to cite or link to this item: http://uvadoc.uva.es/handle/10324/9056
Title: HMG CoA Reductase Inhibitors and Impotence Two Case Series from the Spanish and French Drug Monitoring Systems
Authors: Carvajal García-Pando, Alfonso
Macías, Diego
Sáinz Gil, María
Ortega, Sara
Martín Arias, Luis
Velasco Martín, Alfonso
Bagheri, Haleh
Lapeyre-Mestre, Maryse
Montastruc, Jean Louis
Issue Date: 2006
Publisher: Springer Verlag
Description: Producción Científica
Citation: Drug Safety, 2006; 29 (2): 143-149
Abstract: Objective: HMG CoA Reductase inhibitors, more commonly called statins, are used in the pharmacological management of hyperlipidaemia. At present, the use of these drugs is increasing worldwide. They have been linked to certain adverse drug reactions, including impotence. The aim of the present study is to explore the basis of the association between statin use and impotence using data from spontaneous reports. Method: We analysed the cases of impotence associated with statins that were collected by the Spanish and French pharmacovigilance systems. We used cases of impotence as a numerator and consumption data as a denominator to estimate the cumulative reported incidence of impotence. Results: Thirty-eight cases of impotence associated with statins have been identified in the database of the Spanish pharmacovigilance system; overall, there was a temporal sequence of events in all cases and the adverse reaction disappeared after drug withdrawal in 93% of the cases. Sixteen patients had also been treated with other drugs. In France, 37 cases were collected. In 85% of these cases recovery from the adverse reaction was observed after drug withdrawal; there was a positive rechallenge in five cases, and 15 patients were receiving other drugs at the same time. No significant differences among reported incidences with different statins were found. Conclusion: Considering the widespread use of this drug class and the under-reporting of this particular reaction it could affect a large number of patients. The reaction seems to be reversible in most of the cases after drug withdrawal. Doctors should be aware of this potential adverse reaction when prescribing statins to their patients.
Keywords: Medicamentos - Efectos secundarios
Impotencia sexual
ISSN: 0114-5916
Peer Review: SI
DOI: 10.2165/00002018-200629020-00004
Language: eng
URI: http://uvadoc.uva.es/handle/10324/9056
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:DEP05 - Artículos de revista

Files in This Item:
File Description SizeFormat 
PD-214 .pdfPD-214198,39 kBAdobe PDFThumbnail
View/Open

This item is licensed under a Creative Commons License Creative Commons

Suggestions
University of Valladolid
Powered by MIT's. DSpace software, Version 5.5
UVa-STIC